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Abstract The international programme to sequence the 4.2 Mb 
genome of Bacillus subtilis, a model Gram-positive bacterium, is 
a joint project involving European, Japanese and US research 
groups. To date ca. 3.0 Mb of the genome has been sequenced, 
with the remaining 1.2 Mb expected to be completed in 1997. The 
amenability of B. subtilis to genetic manipulation, combined with 
the availability of extensive expertise on its biochemistry and 
physiology, makes this bacterium a valuable organism in which 
to investigate the properties of genes for which functions cannot 
be readily ascribed by standard methods. 
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1. Introduction 
Bacteria of the genus Bacillus (type strain Bacillus subtilis 
Marburg) are aerobic, endospore-forming Gram-positive 
rods. The genus is one of the most widely distributed and 
metabolically diverse, with representatives found in the soil 
and associated water sources [1]. Bacillus species have a 
long history of exploitation by mankind [2,3]; their metabolic 
diversity has been employed in a wide range of industrial 
processes, including the production of hydrolytic enzymes 
(e.g. alkaline proteases, co-amylases [4]), polypeptide antibiot- 
ics (e.g. bacitracin, gramicidins, polymyxins [5]), biochemicals 
(e.g. nucleosides for conversion to flavour enhancers [6]) and 
insecticides (e.g. 8-endotoxins [7]). Bacillus subtilis (var. natto) 
has been used throughout this century for the fermentation of
soybeans into Natto, a traditional Japanese food. The con- 
sumption of some l0 s kg of Natto annually, the low reported 
incidence of pathogenicity and the widespread use of its prod- 
ucts, and those of its close relatives, in the food, beverage and 
detergents industries has resulted in the granting of GRAS 
(generally regarded as safe) status to B. subtilis by the U.S. 
Food and Drug Administration (FDA). 
Our understanding of the biochemistry, physiology and ge- 
netics of B. subtilis is second only to that of Escherichia coli 
(see [8]), from which it diverged more than 2 billion years ago 
[9]. Three important characteristics of B. subtilis are respon- 
sible for the extent of this knowledge base : (i) the elaboration 
of an efficient natural genetic transformation system [10], the 
first discovered in non-pathogenic micro-organism [11]; (ii) the 
production of commercially important hydrolytic enzymes 
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and bioactive compounds [2]; (iii) the ability to differentiate 
into heat-, desiccation- and chemical-resistant e dospores [12]. 
Most molecular biological and genetic methods that are avail- 
able for E. coli have been developed for B. subtilis [13,14]. 
However, one particular advantage this bacterium has over 
E. coli is that genes are very easily introduced into the chro- 
mosome using the active recombination pathways in R sub- 
tilis [15]. This greatly facilitates the generation of transcrip- 
tional and translation fusions, insertional mutations and 
merodiploids, and the introduction of controllable promoters 
upstream of target genes. This property is being fully 
exploited in the gene functional analysis programme (see Sec- 
tion 4, below). 
B. subtilis and closely related bacilli secrete industrially im- 
portant enzymes directly into the growth medium at concen- 
trations in excess of 10 g/1 and this has provided the basis of 
much of the commercial interest in these bacteria [2,16]. How- 
ever, attempts to use B. subtilis to secrete heterologous pro- 
teins at commercially significant concentrations have, with few 
exceptions, met with little success. The reasons for these fail- 
ures have proved to be complex, but include the stability of 
cloning vectors, the production of extracellular proteases and 
incompatibilities between the secretion apparatus and target 
proteins. Many of these problems are currently being tackled 
in a EU-funded research programme, co-ordinated by Dr 
Sierd Bron (Groningen, The Netherlands). 
2. Genome sequencing programme 
The genome of B. subtilis strain 168 is approximately 4.2 
Mb in size and has the benefit of extensive genetic [17] and 
physical [18] maps. The international programme to sequence 
the genome involves European, Japanese and US research 
groups. The genome has been divided into regions which, in 
most cases, are bordered by previously sequenced genes and 
assigned to participants in the consortium (Fig. 1). The Euro- 
pean groups are responsible for sequencing 3.9 Mb. They are 
funded by the European Commission under its Biotechnology 
Programme and are co-ordinated by Dr Frank Kunst (Institut 
Pasteur, Paris [19]). The Japanese groups, responsible for 1.3 
Mb, are supported by the Ministry of Education, Science and 
Culture of Japan and are co-ordinated by Professor Naotake 
Ogasawara (Nara Institute of Science and Technology [20]). 
To date more than 70% of the genome has been sequenced (3 
Mb) and the entire sequence should be available within 12 
months. 
The European sequence data are collected and verified at 
the Institut Pasteur under the supervision of Dr Antoine Dan- 
chin [21], where it is complied into a database called SubtiList. 
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Fig. 1. Assignment of regions of the B. subtilis genome. 
SubtiList is implemented on microcomputers with the Macin- 
tosh operating system via the 4th Dimension© relational da- 
tabase software (4D, ACI). Its user-friendly interface allows 
easy access to information on the genetic map, DNA and 
protein sequences, equenced contigs, locations of control re- 
gions, gene descriptions and selected literature. The latest 
publicly available version of the SubtiList (currently ver. 10) 
is available on-line through an anonymous ftp from 'ftp.pas- 
teur.fr' or IP number 157.99.64.12 in the directory '/pub/Gen- 
omeDB/SubtiList'. 
3. Sequencing strategies 
Systemic sequencing of microbial genomes has been 
achieved either by shotgun cloning the entire chromosome 
and assembling the resulting sequences in silico [22] or by 
creating an ordered library of large, overlapping chromosomal 
fragments which are subsequently sequenced individually [23]. 
The multi-national rchitecture of the B. subtilis sequencing 
consortium has dictated the latter approach, with individual 
groups being responsible for developing their own sequencing 
strategy. Whilst cosmid libraries have been used to create 
overlapping libraries of individual Saccharomyces cerevisiae 
[23] and Caenorhabditis elegans [24] chromosomes and for 
the genome of Mycobacterium leprae [25], and lambda li- 
braries for the E. coli genome [26], it has proved impossible 
to construct cosmid or lambda libraries that completely cover 
the B. subtilis chromosome. This is because large fragments of 
B. subtilis DNA have been found to be unstable in E. coli due 
to their high AT content (43% GC) and the elevated levels of 
expression of many B. subtilis genes in this host [27,28]. 
The frequent instability and/or toxicity of B. subtilis DNA 
in E. coli has necessitated the development of alternative gen- 
.me sequencing strategies. Azevedo and co-workers [29] 
avoided the use of E. coli as an intermediate host for generat- 
ing a collection of large, overlapping DNA fragments by con- 
structing an ordered library of the B. subtilis genome in yeast 
artificial chromosomes (pYACs). A collection of 59 pYAC 
clones was mapped by hybridisation, using previously cloned 
genes as probes, and the pYACs ordered in four contigs that 
covered > 98% of the B. subtilis chromosome. PFGE-purified 
pYAC DNA was fragmented and cloned into M 13-based vec- 
tors for sequencing [30]. The generation of sufficient quantities 
of pYAC DNA for subsequent fragmentation and cloning 
remains the main limitation of this approach. 
Glaser and colleagues [27] addressed the problem of the 
instability of large fragments of B. subtilis DNA in E. coli 
by developing a method for directed chromosome walking. 
This method exploits the ease with which B. subtilis can 
take up exogenous DNA and integrate it into its chromosome 
by homologous recombination [15]. An E. coli plasmid 
(pDIA5304), unable to replicate in B. subtilis and carrying a 
fragment from the end of a cloned DNA region, is integrated 
into the chromosome by a Campbell-type recombination 
event [27]. The adjacent chromosomal DNA is then rescued 
by digestion with appropriate restriction endonucleases, self- 
ligated and then transformed back into E. coli using the origin 
of replication and antibiotic resistance marker of the original 
integration vector. Even using this methodology, instability/ 
toxicity can still present problems. However, the use of an 
E. coli host which maintains normally high copy number plas- 
mids at a low copy number, such as E. coli TP611 [31], has 
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facilitated the cloning and maintenance of many previously 
unstable fragments. 
Despite the development of new methodologies, we and 
others have continued to find lambda clones a valuable start- 
ing material for sequencing, particular when used in combina- 
tion with newer technologies for filling gaps between sequence 
islands. A particularly useful innovation has been to use 
pYAC clones from the Azevedo collection [29] as hybridisa- 
tion probes for the selection of a set of )~-phage clones cover- 
ing specific regions of the chromosome. 
The advent of long accurate PCR permits the amplification 
of chromosomal segments of up to 35 kb [32]. In addition, the 
optimisation of the enzymology for dye terminator and dye 
primer technology for automated sequencing has simplified 
methods for the direct sequencing of PCR products and for 
the automation of template preparation. This has led us to 
develop an approach based on the use of a conventional shot- 
gun sequencing procedure into a general purpose E. coli se- 
quencing vector [33]. DNA from lambda clones or DNA gen- 
erated by long PCR from lambda inserts or chromosomal 
DNA is randomly fragmented by treatment with DNase I in 
the presence of manganese ions and fragments of between 0.5 
and 2.5 kb cloned into pUC18. After automated sequencing, 
DNA sequences are assembled using a contig building pro- 
gramme and any gaps filled by primer walking, by sequencing 
directly from PCR products or by the fragmentation of gap- 
filling PCR products and cloning as smaller fragments (250 
500 bases). 
We have used these techniques to complete the 114 kb 
region from pheA (240 °) to dnaB (256°). Typically, we and 
others have found that > 90% of the coding capacity encodes 
for ORFs, four out of five of which are orientated in the 
direction of movement of the replication fork. All three initia- 
tion codons are used, with a frequency ATG >> TTG > GTG. 
In addition we have found the unusual ATT start codon in 
front of the gene coding for initiation factor 3 (IF3, unpub- 
lished). Putative ribosome binding sites are generally easy to 
identify because they are more conserved with respect o the 
3'-end of 16S rRNA than are their counterparts in E. coli. 
This has been attributed to the absence in B. subtilis of a 
ribosomal protein equivalent o the S1 protein of E. coli 
[34]. In contrast, B. subtilis elaborates at least 10 distinct sig- 
ma factors [35], each of which direct RNA polymerase to a 
distinct set of promoter sequences. Consequently, searches for 
promoter sequences in silico are at best problematical nd 
sometimes misleading, and we prefer to await confirmation 
by promoter mapping studies. 
Another feature that is emerging from sequencing and con- 
comitant functional analysis tudies of B. subtilis is the appar- 
ent duplication of enzymic activities. For example, B. subtilis 
encodes at least three signal peptidases [36,37], up to four 
distinct alkaline phosphatases [38] and two Lon proteases 
([39] and unpublished). Whilst it is not always obvious what 
benefits are conferred by this redundancy, it appears in some 
cases that distinct enzyme activities are required uring vege- 
tative growth and sporulation. 
4. Systematic function analysis 
About half of the genes identified during the systematic 
sequencing of bacterial genomes have no function ascribed 
to them - they either have no homology with sequences in 
the databases or the function of their homologues is also 
unknown. In order to optimise the value of the data from 
the B, subtilis genome sequencing project, and to facilitate 
increased industrial usage of B. subtilis, a consortium of 19 
European laboratories, co-ordinated by Dr S. Dusko Ehrlich 
(INRA, Jouy en Josas, France), has recently initiated a sys- 
tematic function analysis of B. subtilis genes. A parallel pro- 
gramme has been initiated in Japan on genes identified in their 
sequencing programme. The prime objective is to assign target 
genes to categories of cellular function including: (i) the me- 
tabolism of small molecules; (ii) macromolecular metabolism; 
(iii) cell structures; (iv) stress and stationary phase; and (v) cell 
processes. More detailed secondary and tertiary analysis will 
follow. The work programme is divided into resource and 
function-oriented consortia. The resource consortium is re- 
sponsible for the production of a collection of standard mu- 
tant strains and their primary characterisation u der defined 
growth conditions by transcriptional nalysis and 3D protein 
profiles. Mutants are generated with integrational vectors, de- 
veloped in Ehrlich's laboratory, that facilitate tandem dupli- 
cation of the target gene. One copy of the gene is a non- 
functional deletion under the control of its native promoter 
and transcriptionally fused to a lacZ reporter. The second, 
wild-type copy of the gene is under the control of an IPTG- 
inducible promoter, The latter permits the selection and ana- 
lysis of mutations even of genes that are essential for growth 
and/or viability. 
The function-oriented consortium will assign target genes to 
the various function categories. This will be achieved system- 
atically at three levels, initially as a tentative assignment by 
high throughput phenotypic tests, then by more elaborated 
tests and finally by specific detailed analysis. A relational da- 
tabase, MICADO (MICrobial Advanced Database Organisa- 
tion), in under construction at INRA for the collation of 
genetic and physical maps, DNA sequences, microbial strains 
and the data derived from the functional analysis programme. 
The database can be accessed on the World Wide Web at 
'http ://locus.jouy.inra.frl'. 
The combination of highly co-ordinated genome sequencing 
and functional analysis programmes i unique among bacter- 
ial systems, the result of unprecedented co-operation between 
researchers in three continents. In addition to their value to 
the Bacillus scientific and industrial communities, the results 
will be of interest o those involved in the analysis of organ- 
isms for which genome sequences are known, but for which 
genetic manipulation and physiological studies are either im- 
possible or, at best, extremely difficult to perform. 
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